4D Molecular Therapeutics Inc (NASDAQ: FDMT) Rose 59.4% From Its 52-Week Low, But YTD Numbers Rise 14.76%. Here’s What You Need To Know At This Time
During the last session, 4D Molecular Therapeutics Inc (NASDAQ:FDMT)’s traded shares were 0.32 million, with the beta value of the company hitting 2.94. At the